Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 3Completed 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 58Colonic Neoplasms 24Rectal Neoplasms 22Neoplasms 19Pancreatic Neoplasms 18Neoplasm Metastasis 17Esophageal Neoplasms 9Stomach Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Small Cell Lung Carcinoma 5Lung Neoplasms 5Glioma 5Glioblastoma 5Brain Neoplasms 5Neuroblastoma 4Gliosarcoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Renal Cell 4Melanoma 3Intestinal Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Sarcoma, Ewing 2Recurrence 2Rectal Diseases 2Ovarian Neoplasms 2Oligodendroglioma 2

Interventions

Irinotecan 3alectinib 1Leucovorin 1KRN-330 1Fluorouracil 1Cetuximab 1Bevacizumab 1Ascorbic Acid 1ABT-165 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Intestinal Neoplasms × Irinotecan × Clear all
NCT01550510 2025-05-06

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Thomas Jefferson University

Phase 1/2 Terminated
4 enrolled 5 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT00838578 2024-04-26

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Kyowa Kirin Co., Ltd.

Phase 1/2 Terminated
65 enrolled 7 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT03368859 2021-02-09

A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

AbbVie

Phase 2 Terminated
70 enrolled 12 charts
Gastrointestinal

Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡